Cargando…
Impact of an innovative financing and payment model on tuberculosis patients’ financial burden: is tuberculosis care more affordable for the poor?
BACKGROUND: In response to the high financial burden of health services facing tuberculosis (TB) patients in China, the China-Gates TB project, Phase II, has implemented a new financing and payment model as an important component of the overall project in three cities in eastern, central and western...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6431427/ https://www.ncbi.nlm.nih.gov/pubmed/30904025 http://dx.doi.org/10.1186/s40249-019-0532-x |
_version_ | 1783405921819426816 |
---|---|
author | Jiang, Wei-Xi Long, Qian Lucas, Henry Dong, Di Chen, Jia-Ying Xiang, Li Li, Qiang Huang, Fei Wang, Hong Elbers, Chris Cobelens, Frank Tang, Sheng-Lan |
author_facet | Jiang, Wei-Xi Long, Qian Lucas, Henry Dong, Di Chen, Jia-Ying Xiang, Li Li, Qiang Huang, Fei Wang, Hong Elbers, Chris Cobelens, Frank Tang, Sheng-Lan |
author_sort | Jiang, Wei-Xi |
collection | PubMed |
description | BACKGROUND: In response to the high financial burden of health services facing tuberculosis (TB) patients in China, the China-Gates TB project, Phase II, has implemented a new financing and payment model as an important component of the overall project in three cities in eastern, central and western China. The model focuses on increasing the reimbursement rate for TB patients and reforming provider payment methods by replacing fee-for-service with a case-based payment approach. This study investigated changes in out-of-pocket (OOP) health expenditure and the financial burden on TB patients before and after the interventions, with a focus on potential differential impacts on patients from different income groups. METHODS: Three sample counties in each of the three prefectures: Zhenjiang, Yichang and Hanzhong were chosen as study sites. TB patients who started and completed treatment before, and during the intervention period, were randomly sampled and surveyed at the baseline in 2013 and final evaluation in 2015 respectively. OOP health expenditure and percentage of patients incurring catastrophic health expenditure (CHE) were calculated for different income groups. OLS regression and logit regression were conducted to explore the intervention’s impacts on patient OOP health expenditure and financial burden after adjusting for other covariates. Key-informant interviews and focus group discussions were conducted to understand the reasons for any observed changes. RESULTS: Data from 738 (baseline) and 735 (evaluation) patients were available for analysis. Patient mean OOP health expenditure increased from RMB 3576 to RMB 5791, and the percentage of patients incurring CHE also increased after intervention. The percentage increase in OOP health expenditure and the likelihood of incurring CHE were significantly lower for patients from the highest income group as compared to the lowest. Qualitative findings indicated that increased use of health services not covered by the standard package of the model was likely to have caused the increase in financial burden. CONCLUSIONS: The implementation of the new financing and payment model did not protect patients, especially those from the lowest income group, from financial difficulty, due partly to their increased use of health service. More financial resources should be mobilized to increase financial protection, particularly for poor patients, while cost containment strategies need to be developed and effectively implemented to improve the effective coverage of essential healthcare in China. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s40249-019-0532-x) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6431427 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-64314272019-04-04 Impact of an innovative financing and payment model on tuberculosis patients’ financial burden: is tuberculosis care more affordable for the poor? Jiang, Wei-Xi Long, Qian Lucas, Henry Dong, Di Chen, Jia-Ying Xiang, Li Li, Qiang Huang, Fei Wang, Hong Elbers, Chris Cobelens, Frank Tang, Sheng-Lan Infect Dis Poverty Research Article BACKGROUND: In response to the high financial burden of health services facing tuberculosis (TB) patients in China, the China-Gates TB project, Phase II, has implemented a new financing and payment model as an important component of the overall project in three cities in eastern, central and western China. The model focuses on increasing the reimbursement rate for TB patients and reforming provider payment methods by replacing fee-for-service with a case-based payment approach. This study investigated changes in out-of-pocket (OOP) health expenditure and the financial burden on TB patients before and after the interventions, with a focus on potential differential impacts on patients from different income groups. METHODS: Three sample counties in each of the three prefectures: Zhenjiang, Yichang and Hanzhong were chosen as study sites. TB patients who started and completed treatment before, and during the intervention period, were randomly sampled and surveyed at the baseline in 2013 and final evaluation in 2015 respectively. OOP health expenditure and percentage of patients incurring catastrophic health expenditure (CHE) were calculated for different income groups. OLS regression and logit regression were conducted to explore the intervention’s impacts on patient OOP health expenditure and financial burden after adjusting for other covariates. Key-informant interviews and focus group discussions were conducted to understand the reasons for any observed changes. RESULTS: Data from 738 (baseline) and 735 (evaluation) patients were available for analysis. Patient mean OOP health expenditure increased from RMB 3576 to RMB 5791, and the percentage of patients incurring CHE also increased after intervention. The percentage increase in OOP health expenditure and the likelihood of incurring CHE were significantly lower for patients from the highest income group as compared to the lowest. Qualitative findings indicated that increased use of health services not covered by the standard package of the model was likely to have caused the increase in financial burden. CONCLUSIONS: The implementation of the new financing and payment model did not protect patients, especially those from the lowest income group, from financial difficulty, due partly to their increased use of health service. More financial resources should be mobilized to increase financial protection, particularly for poor patients, while cost containment strategies need to be developed and effectively implemented to improve the effective coverage of essential healthcare in China. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s40249-019-0532-x) contains supplementary material, which is available to authorized users. BioMed Central 2019-03-24 /pmc/articles/PMC6431427/ /pubmed/30904025 http://dx.doi.org/10.1186/s40249-019-0532-x Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Jiang, Wei-Xi Long, Qian Lucas, Henry Dong, Di Chen, Jia-Ying Xiang, Li Li, Qiang Huang, Fei Wang, Hong Elbers, Chris Cobelens, Frank Tang, Sheng-Lan Impact of an innovative financing and payment model on tuberculosis patients’ financial burden: is tuberculosis care more affordable for the poor? |
title | Impact of an innovative financing and payment model on tuberculosis patients’ financial burden: is tuberculosis care more affordable for the poor? |
title_full | Impact of an innovative financing and payment model on tuberculosis patients’ financial burden: is tuberculosis care more affordable for the poor? |
title_fullStr | Impact of an innovative financing and payment model on tuberculosis patients’ financial burden: is tuberculosis care more affordable for the poor? |
title_full_unstemmed | Impact of an innovative financing and payment model on tuberculosis patients’ financial burden: is tuberculosis care more affordable for the poor? |
title_short | Impact of an innovative financing and payment model on tuberculosis patients’ financial burden: is tuberculosis care more affordable for the poor? |
title_sort | impact of an innovative financing and payment model on tuberculosis patients’ financial burden: is tuberculosis care more affordable for the poor? |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6431427/ https://www.ncbi.nlm.nih.gov/pubmed/30904025 http://dx.doi.org/10.1186/s40249-019-0532-x |
work_keys_str_mv | AT jiangweixi impactofaninnovativefinancingandpaymentmodelontuberculosispatientsfinancialburdenistuberculosiscaremoreaffordableforthepoor AT longqian impactofaninnovativefinancingandpaymentmodelontuberculosispatientsfinancialburdenistuberculosiscaremoreaffordableforthepoor AT lucashenry impactofaninnovativefinancingandpaymentmodelontuberculosispatientsfinancialburdenistuberculosiscaremoreaffordableforthepoor AT dongdi impactofaninnovativefinancingandpaymentmodelontuberculosispatientsfinancialburdenistuberculosiscaremoreaffordableforthepoor AT chenjiaying impactofaninnovativefinancingandpaymentmodelontuberculosispatientsfinancialburdenistuberculosiscaremoreaffordableforthepoor AT xiangli impactofaninnovativefinancingandpaymentmodelontuberculosispatientsfinancialburdenistuberculosiscaremoreaffordableforthepoor AT liqiang impactofaninnovativefinancingandpaymentmodelontuberculosispatientsfinancialburdenistuberculosiscaremoreaffordableforthepoor AT huangfei impactofaninnovativefinancingandpaymentmodelontuberculosispatientsfinancialburdenistuberculosiscaremoreaffordableforthepoor AT wanghong impactofaninnovativefinancingandpaymentmodelontuberculosispatientsfinancialburdenistuberculosiscaremoreaffordableforthepoor AT elberschris impactofaninnovativefinancingandpaymentmodelontuberculosispatientsfinancialburdenistuberculosiscaremoreaffordableforthepoor AT cobelensfrank impactofaninnovativefinancingandpaymentmodelontuberculosispatientsfinancialburdenistuberculosiscaremoreaffordableforthepoor AT tangshenglan impactofaninnovativefinancingandpaymentmodelontuberculosispatientsfinancialburdenistuberculosiscaremoreaffordableforthepoor |